Lobbying Activity Report

331-36120

Organization: Boehringer Ingelheim Canada Ltd
Associated registration: 9781-331-34
Lobbying Activity date: 2024-07-03
Arranged a meeting: No
Posted date: 2024-07-08

In-house lobbyists who participated in the lobbying activity: Andrew Ransom
Lana Solberg
Marc O'Loughlin
Senior Public Office Holders who were lobbied in this activity: Elaine Cross, Executive Director
Innovation Programs & Partnership, Environment and Climate Change Strategy

Chris Koski, Director, Clean Government
Environment and Climate Change Strategy

Amandeep Singh, Parliamentary Secretary
Environment and Climate Change Strategy
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Provide information on relevant healthcare partnerships that impact the BC life science ecosystem, have a positive impact on the environment, and support access to healthcare for BC patients.
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
 Environment
To actively promote the contributions and positive impact of pharmaceutical innovation and the innovative pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system. Ensure any changes to pharmaceutical legislation support appropriate government reimbursement of innovative pharmaceuticals. Work with the Ministry of Health regarding public reimbursement of our innovative pharmaceutical products
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
 Health
 
Senior officer who filed this Lobbying Activity Report: Mark Lewis
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: